Cargando…

The hypermethylation of the CDKN2A and CHFR promoter region is a key regulatory mechanism of CDKN2A and CHFR expression in esophageal squamous cell carcinoma

BACKGROUND: The aim of this study was to evaluate the correlation between CDKN2A and CHFR expression and the methylation status of the CpG island in the promoter region of esophageal squamous cell carcinoma (ESCC) cell lines, radioresistant ESCC cell lines and ESCC clinical tissue specimens. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Xinyu, Cheng, Min, Chen, Wen, Wu, Xianning, Xie, Mingran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797354/ https://www.ncbi.nlm.nih.gov/pubmed/35116815 http://dx.doi.org/10.21037/tcr.2019.04.19

Ejemplares similares

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia
por: Honda, T, et al.
Publicado: (2004)

Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel
por: Yun, Tianyang, et al.
Publicado: (2015)

Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis
por: Shi, Hua, et al.
Publicado: (2016)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review
por: Sun, Zhulei, et al.
Publicado: (2017)

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma
por: González-Borja, Iranzu, et al.
Publicado: (2021)

CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process
por: Dai, Dongjun, et al.
Publicado: (2019)

Chfr and RNF8 synergistically regulate ATM activation
por: Wu, Jiaxue, et al.
Publicado: (2011)

TOPK and PTEN participate in CHFR mediated mitotic checkpoint()
por: Shinde, Swapnil R., et al.
Publicado: (2013)

CHFR is important for the first wave of ubiquitination at DNA damage sites
por: Liu, Chao, et al.
Publicado: (2013)

Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment
por: Li, Yuan, et al.
Publicado: (2019)

CHFR negatively regulates SIRT1 activity upon oxidative stress
por: Kim, Myungjin, et al.
Publicado: (2016)

Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers
por: Zhang, Di, et al.
Publicado: (2017)

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
por: Ding, Yong, et al.
Publicado: (2017)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Arya, Ashutosh Kumar, et al.
Publicado: (2017)

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
por: Derks, Sarah, et al.
Publicado: (2013)

Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells
por: Matsusaka, Takahiro, et al.
Publicado: (2004)

CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
por: Luo, Hong, et al.
Publicado: (2021)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition
por: Kang, Dongmin, et al.
Publicado: (2002)

Ubiquitin ligase CHFR mediated degradation of VE-cadherin through ubiquitylation disrupts endothelial adherens junctions
por: Tiruppathi, Chinnaswamy, et al.
Publicado: (2023)

CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis
por: He, Feiyun, et al.
Publicado: (2023)

Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
por: Cha, Yongjun, et al.
Publicado: (2018)

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013)

Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR
por: Castellano, Leandro, et al.
Publicado: (2017)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer
por: Brodie, Seth A., et al.
Publicado: (2015)

Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer
por: Maekawa, Hiroshi, et al.
Publicado: (2020)

CDKN2A methylation in esophageal cancer: a meta-analysis
por: Zhou, Chongchang, et al.
Publicado: (2017)

The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer
por: Zhang, Xu, et al.
Publicado: (2018)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population
por: Cui, Xiaopeng, et al.
Publicado: (2021)

CHFR promotes the migration of human gastric cancer cells by inducing epithelial-to-mesenchymal transition in a HDAC1-dependent manner
por: Yang, Shangwen, et al.
Publicado: (2019)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
por: Chen, Xiangling, et al.
Publicado: (2021)

Detection and significance of human papillomavirus, CDKN2A (p16) and CDKN1A (p21) expression in squamous cell carcinoma of the larynx
por: Chernock, Rebecca D., et al.
Publicado: (2012)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain
por: Fukuda, Tomokazu, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k24blsl7d97iqpen3gv65micn9